Heba A. Abou‐Taleb
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 15
- Advanced Drug Delivery Systems 12
- Drug Solubulity and Delivery Systems 9
-
- Lipid Membrane Structure and Behavior 4
- Co-authors
- Heba F. Salem (9 shared papers)Rasha M. Kharshoum (8 shared papers)Jelan A. Abdel-Aleem (5 shared papers)Mohamed A. El‐Mokhtar (4 shared papers)Mostafa F. Al-Hakkani (3 shared papers)Mohammed S. Saddik (4 shared papers)Hamdy Abdelkader (9 shared papers)Ahmed A. H. Abdellatif (2 shared papers)
- Journals
- Pharmaceutics (9 papers)AAPS PharmSciTech (3 papers)Pharmaceuticals (3 papers)Pharmaceutical Development and Technology (2 papers)Drug Delivery (2 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Heba A. Abou‐Taleb
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 110
- Pharmaceutical Science 473
- Biomaterials 166
- Rehabilitation 75
- Dermatology 90
- Molecular Medicine 44
Countries citing papers authored by Heba A. Abou‐Taleb
This map shows the geographic impact of Heba A. Abou‐Taleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba A. Abou‐Taleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba A. Abou‐Taleb more than expected).
Fields of papers citing papers by Heba A. Abou‐Taleb
This network shows the impact of papers produced by Heba A. Abou‐Taleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba A. Abou‐Taleb. The network helps show where Heba A. Abou‐Taleb may publish in the future.
Co-authors
The 25 scholars most cited alongside Heba A. Abou‐Taleb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 106 | |
| 2 | 2021 | 74 | |
| 3 | 2020 | 71 | |
| 4 | 2021 | 64 | |
| 5 | 2019 | 62 | |
| 6 | 2020 | 60 | |
| 7 | 2019 | 60 | |
| 8 | 2018 | 53 | |
| 9 | 2019 | 52 | |
| 10 | 2020 | 46 | |
| 11 | 2018 | 46 | |
| 12 | 2021 | 44 | |
| 13 | 2017 | 38 | |
| 14 | 2022 | 35 | |
| 15 | 2021 | 34 | |
| 16 | 2019 | 29 | |
| 17 | 2019 | 27 | |
| 18 | 2019 | 25 | |
| 19 | 2018 | 22 | |
| 20 | 2022 | 20 |
About Heba A. Abou‐Taleb
Heba A. Abou‐Taleb is a scholar working on Pharmaceutical Science, Molecular Biology, Dermatology, Pharmacology and Analytical Chemistry, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (15 papers), Advanced Drug Delivery Systems (12 papers), Drug Solubulity and Delivery Systems (9 papers), Analytical Methods in Pharmaceuticals (4 papers), Lipid Membrane Structure and Behavior (4 papers), Crystallization and Solubility Studies (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Pharmaceutical Science (473 citations), Biomaterials (166 citations), Rehabilitation (75 citations), Dermatology (90 citations) and Molecular Medicine (44 citations). Heba A. Abou‐Taleb has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Heba F. Salem, Rasha M. Kharshoum, Jelan A. Abdel-Aleem, Mohamed A. El‐Mokhtar, Mostafa F. Al-Hakkani, Mohammed S. Saddik, Hamdy Abdelkader, Ahmed A. H. Abdellatif, M. Omar and Nermin E. Eleraky. Their work appears in journals such as Pharmaceutics, AAPS PharmSciTech, Pharmaceuticals, Pharmaceutical Development and Technology and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.